Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Amgen (NQ: AMGN)
178.39 USD  +2.31 (+1.31%)
Official Closing Price  /  Updated: 5:58 PM EDT, Jun 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,915,551
Open 176.04
Bid (Size) 175.50 (6)
Ask (Size) 178.44 (9)
Prev. Close 176.08
Today's Range 175.40 - 178.55
52wk Range 166.30 - 210.19
Shares Outstanding 661,706,000
Dividend Yield 2.96%
Performance
YTD
-7.04%
-7.04%
1 Month
+4.99%
+4.99%
3 Month
-6.75%
-6.75%
6 Month
-6.15%
-6.15%
1 Year
-3.02%
-3.02%
Top News
More News
Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019
Phase 2 Single-Arm BLAST Study Shows Median Overall Survival of 36.5 Months in Patients With Minimal Residual Disease-Positive Acute Lymphoblastic Leukemia Read More
from PR Newswire
FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)
Approval Based on Totality of Evidence Demonstrating KANJINTI is Biosimilar to Herceptin Read More
from PR Newswire
More News
Read More
Amgen Publishes Offer Document With Respect To The Recommended Public Cash Offer To The Shareholders Of Nuevolution
from PR Newswire
Amgen To Present At The Goldman Sachs 40th Annual Global Healthcare Conference
from PR Newswire
Our Commitment to Patients and Beyond: Amgen 2018 Responsibility Highlights Report
category Diversity & Inclusion , ReportAlert , NASDAQ: AMGN , and 13 more.
from 3BL Media: Corporate Social Responsibility, Energy and Health News
Amgen Announces First Clinical Data Evaluating Investigational KRAS(G12C) inhibitor AMG 510 at ASCO 2019
from PR Newswire
Amgen Highlights the Versatility of the BiTE® Immuno-Oncology Platform in Multiple Tumour Types at ASCO 2019
from PR Newswire
Shares of cancer-therapy companies skyrocket after Pfizer acquisition news
category Biotechnology , NVO , MRTX , and 19 more.
from MarketWatch
ADDING MULTIMEDIA Socati Board of Director Appointments Bring Significant Leadership Experience to Accelerate Company Growth, Advance Hemp Industry
from Business Wire News Releases
UPDATE 1-U.S. drugmakers file lawsuit against requiring drug prices in TV ads
category companyNews
from Reuters: Company News
Drugmakers file lawsuit to block rule requiring drug prices in TV ads
category MRK , General , AMGN , and 2 more.
from MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.